ART-hero-image-1920
Apples_to_Apples_Title_Card_fullsize

 

Apples to Apples: Playing the Comparability Game in Biotherapeutics Development ​


Comparability studies are a significant issue for those working in biotherapeutics development, as undetected product changes are considered high risk. Listen as Kevin Hennegan, Lisa Erickson and Sarah Roemer take us through several considerations when Playing the Comparability Game in Biotherapeutics Development.

Your browser does not support the audio tag.


Play another episode from our library

ART_logo_reversed_horizontal_stacked


Listen and subscribe on your favorite podcast player

  apple-podcast-badge EN_Google_Podcasts_Badge_1x spotify-podcast-badge-blk-grn-330x80 

  • Privacy Policy

© 2023 Veristat, Inc. All Rights Reserved.

Return to Top